Given the unique paradigm of how ACE2 influences infection transmission and then the cardiac and pulmonary response to the infection, it is possible that there are differences in the desired ACE2 and Ang(1–7) levels for minimization of the infection and, then, the attenuation of the cardiopulmonary effects of the infection once infection has occurred. This evidence concerns the gene ACE2 and infection.